CClinicalTrials.gg
CompletedNCT04289129Updated Dec 17, 2020

The Viscoelastic Properties of Lower Extremity's Muscles

An interventional study of Myotonometric evaluation in Muscle Loss, sponsored by Hasan Kalyoncu University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-12-17.

Sponsored by Hasan Kalyoncu University · Not applicable, Interventional, and Screening

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jun 2018, registered Feb 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
389
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This study aims to create normative values for stiffness, tonus and elasticity in the lower extremity muscles and to determine age and gender differences.

02

Conditions studied

  • Muscle Loss

Keywords

  • Muscle tone
  • viscoelastic properties
  • aging
03

In context

Lead sponsor

Hasan Kalyoncu University is the lead sponsor of 161 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Individuals without any systemic or metabolic diseases, psychological illnesses, or drug abuse; those without any diseases that could cause muscle disease or muscle atrophy; and those who had not undergone any surgery in the musculoskeletal system during the past 3 months were included

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
389 participants (actual)

Study arms

  • Experimental
    men

    Diagnostic Test: Myotonometric evaluation

  • Experimental
    women

    Diagnostic Test: Myotonometric evaluation

Interventions

  • Diagnostic testMyotonometric evaluation

    Vertically placed on the muscle, a probe (3 mm diameter) creates constant pre-excitations (0.18 N) and generates short-term (15 ms), low-force (0.4 N) mechanical stimulations.

06

What researchers measure

Primary outcomes

  1. Myotonometric evaluation

    The muscle tone, stiffness and elasticity of participants are assessed with myoton device for creating normative data

    Time frame: 1 year

07

Study locations

1 site
  • Hasan Kalyoncu Üniversity
    Gaziantep, Turkey
08

References and documents

Publications

  • Correa-de-Araujo R, Harris-Love MO, Miljkovic I, Fragala MS, Anthony BW, Manini TM. The Need for Standardized Assessment of Muscle Quality in Skeletal Muscle Function Deficit and Other Aging-Related Muscle Dysfunctions: A Symposium Report. Front Physiol. 2017 Feb 15;8:87. doi: 10.3389/fphys.2017.00087. eCollection 2017. PubMed 28261109 ↗
  • Perkisas, S., et al., Physiological and architectural changes in the ageing muscle and their relation to strength and function in sarcopenia. European Geriatric Medicine, 2016. 7(3): p. 201-206

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04289129
Lead sponsor
Hasan Kalyoncu University
Responsible party
Serkan Usgu (Associate Professor, Hasan Kalyoncu University) — Principal investigator
First posted
Feb 28, 2020
Start date
Jun 6, 2018
Primary completion
Jan 12, 2019
Completion
Feb 20, 2020
Last update
Dec 17, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion